Omar Serri

3.4k total citations
81 papers, 2.5k citations indexed

About

Omar Serri is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Epidemiology. According to data from OpenAlex, Omar Serri has authored 81 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Endocrinology, Diabetes and Metabolism, 22 papers in Surgery and 17 papers in Epidemiology. Recurrent topics in Omar Serri's work include Pituitary Gland Disorders and Treatments (52 papers), Growth Hormone and Insulin-like Growth Factors (41 papers) and Adrenal and Paraganglionic Tumors (18 papers). Omar Serri is often cited by papers focused on Pituitary Gland Disorders and Treatments (52 papers), Growth Hormone and Insulin-like Growth Factors (41 papers) and Adrenal and Paraganglionic Tumors (18 papers). Omar Serri collaborates with scholars based in Canada, United States and Germany. Omar Serri's co-authors include Jules Hardy, Geneviève Renier, M Somma, Hugues Beauregard, Catherine Beauregard, E Rasio, Anne-Cécile Desfaits, Uyen Truong, R Comtois and Nahla Aris-Jilwan and has published in prestigious journals such as New England Journal of Medicine, JAMA and PLoS ONE.

In The Last Decade

Omar Serri

79 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Omar Serri Canada 26 1.9k 797 514 279 246 81 2.5k
Andrea Giustina Italy 21 2.2k 1.1× 752 0.9× 300 0.6× 315 1.1× 138 0.6× 55 2.7k
Bruno Ambrosi Italy 29 2.3k 1.2× 1.2k 1.5× 262 0.5× 208 0.7× 133 0.5× 56 2.9k
Andrea L. Utz United States 14 1.5k 0.8× 581 0.7× 298 0.6× 238 0.9× 148 0.6× 24 1.9k
Maria Cristina De Martino Italy 28 2.4k 1.2× 1.2k 1.5× 255 0.5× 281 1.0× 157 0.6× 72 3.0k
P E Belchetz United Kingdom 23 1.7k 0.9× 362 0.5× 270 0.5× 279 1.0× 135 0.5× 55 2.4k
Holger S. Willenberg Germany 29 2.5k 1.3× 2.0k 2.5× 160 0.3× 465 1.7× 329 1.3× 105 3.7k
G Pieters Netherlands 27 1.3k 0.7× 420 0.5× 189 0.4× 183 0.7× 85 0.3× 80 1.9k
Tatiana Mancini Italy 13 1.7k 0.9× 736 0.9× 155 0.3× 147 0.5× 74 0.3× 18 2.0k
Genzo Iguchi Japan 28 1.1k 0.6× 337 0.4× 657 1.3× 501 1.8× 91 0.4× 104 2.3k
J. F. Henry France 20 684 0.4× 932 1.2× 180 0.4× 211 0.8× 41 0.2× 52 1.7k

Countries citing papers authored by Omar Serri

Since Specialization
Citations

This map shows the geographic impact of Omar Serri's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Omar Serri with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Omar Serri more than expected).

Fields of papers citing papers by Omar Serri

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Omar Serri. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Omar Serri. The network helps show where Omar Serri may publish in the future.

Co-authorship network of co-authors of Omar Serri

This figure shows the co-authorship network connecting the top 25 collaborators of Omar Serri. A scholar is included among the top collaborators of Omar Serri based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Omar Serri. Omar Serri is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Vallette, Sophie, Shereen Ezzat, Constance L. Chik, et al.. (2012). Emerging trends in the diagnosis and treatment of acromegaly in Canada. Clinical Endocrinology. 79(1). 79–85. 36 indexed citations
3.
Aris-Jilwan, Nahla, et al.. (2012). Apoplexy of A Microprolactinoma During Pregnancy: Case Report and Review of Literature. Endocrine Practice. 18(6). e147–e150. 29 indexed citations
4.
Vallette, Sophie & Omar Serri. (2010). Oral estroprogestin: an alternative low cost therapy for women with postoperative persistent acromegaly?. Pituitary. 13(4). 311–314. 14 indexed citations
5.
Vallette, Sophie, Karim Serri, & Omar Serri. (2009). Cabergoline therapy for prolactinomas: is valvular heart disease a real safety concern?. Expert Review of Cardiovascular Therapy. 8(1). 49–54. 10 indexed citations
6.
Petersenn, Stephan, Jens Bollerslev, Ayman M. Arafat, et al.. (2008). pasireotide LAR is effective in patients Open Repository and Bibliography (University of Liège). 1 indexed citations
7.
Vallette, Sophie, Karim Serri, Juan Rivera, et al.. (2008). Long-term cabergoline therapy is not associated with valvular heart disease in patients with prolactinomas. Pituitary. 12(3). 153–157. 83 indexed citations
8.
Ur, Ehud, et al.. (2006). Canadian guidelines for the management of adult growth hormone deficiency.. PubMed. 29(2). 83–90. 3 indexed citations
9.
Serri, Omar, et al.. (2004). Enhanced Lipoprotein Lipase Secretion and Foam Cell Formation by Macrophages of Patients with Growth Hormone Deficiency: Possible Contribution to Increased Risk of Atherogenesis?. The Journal of Clinical Endocrinology & Metabolism. 89(2). 979–985. 19 indexed citations
10.
Patel, Yogesh, Shereen Ezzat, Constance L. Chik, et al.. (2000). Guidelines for the diagnosis and treatment of acromegaly: a Canadian perspective.. PubMed. 23(3). 172–87. 6 indexed citations
11.
Desfaits, Anne-Cécile, Omar Serri, & Geneviève Renier. (1997). Gliclazide decreases cell-mediated low-density lipoprotein (LDL) oxidation and reduces monocyte adhesion to endothelial cells induced by oxidatively modified LDL. Metabolism. 46(10). 1150–1156. 44 indexed citations
12.
Massoud, Fadi, Omar Serri, Jules Hardy, M Somma, & Hugues Beauregard. (1996). Transsphenoidal adenomectomy for microprolactinomas: 10 to 20 years of follow-up. Surgical Neurology. 45(4). 341–346. 43 indexed citations
13.
Comtois, R, M Somma, E Rasio, et al.. (1993). [Treatment of the non-functioning hypophyseal adenoma].. PubMed. 122(6). 482–7. 1 indexed citations
14.
Renier, Geneviève & Omar Serri. (1991). Effects of Acute and Prolonged Glucose Excess on Growth Hormone Release by Cultured Rat Anterior Pituitary Cells. Neuroendocrinology. 54(5). 521–525. 14 indexed citations
15.
Serri, Omar, M Somma, E Rasio, & Paul Brazeau. (1989). GROWTH HORMONE‐RELEASING FACTOR INCREASES SERUM PROLACTIN CONCENTRATIONS IN NORMAL SUBJECTS AND IN PATIENTS WITH PITUITARY ADENOMAS. Clinical Endocrinology. 30(1). 65–75. 4 indexed citations
16.
Serri, Omar, Françoise Robert, Georges Pelletier, Hugues Beauregard, & Jules Hardy. (1987). Hyperprolactinemia associated with clinically silent adenomas: endocrinologic and pathologic studies; a report of two cases. Fertility and Sterility. 47(5). 792–796. 5 indexed citations
17.
Serri, Omar, et al.. (1987). DISTINCTIVE FEATURES OF PROLACTIN SECRETION IN ACROMEGALIC PATIENTS WITH HYPERPROLACTINAEMIA. Clinical Endocrinology. 27(4). 429–436. 11 indexed citations
18.
Serri, Omar, Hugues Beauregard, E Rasio, & Jules Hardy. (1986). Decreased sensitivity to insulin in women with microprolactinomas. Fertility and Sterility. 45(4). 572–574. 28 indexed citations
19.
Serri, Omar, et al.. (1984). Interaction of Sulpiride with Human Pituitary Dopaminergic Receptors Is Sodium Dependent<sup>1</sup>. Hormone Research. 19(3). 153–157. 4 indexed citations
20.
Serri, Omar, et al.. (1984). Dopaminergic Binding Sites in Human Pituitary Adenomas Other than Prolactinomas. Hormone Research. 19(2). 97–102. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Giustina Breakdown of academic impact, for papers by Bruno Ambrosi Breakdown of academic impact, for papers by Andrea L. Utz Breakdown of academic impact, for papers by Maria Cristina De Martino Breakdown of academic impact, for papers by P E Belchetz Breakdown of academic impact, for papers by Holger S. Willenberg Breakdown of academic impact, for papers by G Pieters Breakdown of academic impact, for papers by Tatiana Mancini Breakdown of academic impact, for papers by Genzo Iguchi Breakdown of academic impact, for papers by J. F. Henry
Rankless by CCL
2026